Gene: NFE2
Official Full Name: nuclear factor, erythroid 2provided by HGNC
Gene Summary: Enables WW domain binding activity; identical protein binding activity; and sequence-specific double-stranded DNA binding activity. Contributes to cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to act upstream of or within several processes, including labyrinthine layer blood vessel development; negative regulation of bone mineralization; and positive regulation of peptidyl-lysine acetylation. Part of RNA polymerase II transcription regulator complex and protein-DNA complex. [provided by Alliance of Genome Resources, Jul 2025]
| Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
|---|---|---|---|---|---|---|
| KOA14605 | NFE2 Knockout cell line (AC16) | Human | NFE2 | 1:3-1:4 | negative | Online Inquiry |
| KOA30048 | NFE2 Knockout cell line (BEAS-2B) | Human | NFE2 | 1:3~1:4 | negative | Online Inquiry |
| KOA45475 | NFE2 Knockout cell line (U-2932) | Human | NFE2 | 1:2-1:4 | negative | Online Inquiry |
| KOA60859 | NFE2 Knockout cell line (TPC-1) | Human | NFE2 | 1:5-1:8 | negative | Online Inquiry |
| KOA76286 | NFE2 Knockout cell line (NCM460) | Human | NFE2 | 1:2~1:3 | negative | Online Inquiry |
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.